Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free by CNBC Markets | April 24, 2026 2:09 am | US Markets Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.
